north - Blog - Global Risk Community2024-03-29T09:55:07Zhttps://globalriskcommunity.com/profiles/blogs/feed/tag/northGlobal Aniline Seeks Support from Downstream MDI, Pricing likely to Level-up Q3 Onwardshttps://globalriskcommunity.com/profiles/blogs/global-aniline-seeks-support-from-downstream-mdi-pricing-likely2020-11-20T13:30:00.000Z2020-11-20T13:30:00.000ZChemAnalysthttps://globalriskcommunity.com/members/ChemAnalyst<div><p><strong><a href="{{#staticFileLink}}8219693053,original{{/staticFileLink}}" target="_blank"><img src="{{#staticFileLink}}8219693053,original{{/staticFileLink}}" class="align-center" alt="8219693053?profile=original" /></a></strong></p><p><strong>About Product:</strong></p><p>Aniline (C6H5NH2) is yellow to brownish oily liquid possessing a musty fishy odor. Aniline consists of an amino group attached to a phenyl group and is the prototypical aromatic amine. Aniline is used as a precursor while producing a wide variety of products such as polyurethane foam, agrochemicals, synthetic dyes, antioxidants, rubber additives, varnishes and explosives. The key raw materials used for the industrial production of Aniline are Benzene, Hydrogen and concentrated Nitric Acid. The most common route for Aniline production is through nitrobenzene which is produced via nitration of Benzene in a continuous or batch process. This is followed by the catalytic vapor phase hydrogenation of Nitrobenzene. About 75% of the global Aniline produced is utilized for the production of methylene diphenyl diisocycanate (MDI), a chemical compound used as a raw material in a wide variety of sectors such as construction and automotive and for consumer products such as household appliances, clothing and footwear.</p><p><strong>Aniline Pricing Overview : <a href="https://www.chemanalyst.com/Pricing-data/aniline-27">https://www.chemanalyst.com/Pricing-data/aniline-27</a></strong></p><p><strong>Asia</strong></p><p>The Asia Pacific Aniline demand surpassed its Q2 quarter levels as strong demand for MDI served as the key contributing factor for improved margins. The Chinese Aniline plant operating levels have been high, driven by increased buying sentiments right from mid-June onwards, which however, is yet to regain strength up to the pre-pandemic levels. Strong recovery in PU foams sector which is used in the furniture and appliances is predicted with many Southeast Asian producers ramping up production feeling the festive push. Indian Aniline demand from the pharmaceutical industry remained high throughout the quarter with several market players receiving shipment orders from the US.</p><p><strong>Europe</strong></p><p>The Aniline market remained pressured in the third quarter as the second wave of COVID-19 wreaked havoc in the Europe Union. The demand for Aniline from the downstream automotive and construction sectors remained muted as the economy continued to grapple with the economic downturn. The pricing curve maintained grounds as there were several reports of downstream MDI plant turnarounds in the region, further pressing the demand side. Production outages at several automotive factories further crimped the Aniline consumption. The quarter ended with the news of Borsod Chem starting production at its new 200 KTPA aniline plant in Hungary during Q3 FY21.</p><p><strong>North America</strong></p><p>Regional Aniline demand witnessed a sharp rebound with strong uptick in PU demand from the automotive and construction sector which remained in doldrums during the second quarter as the nation continued strictest coronavirus-related restrictions on economic activity. The end-use markets reported supply tightness due to logistic disruptions and plant closures in several US provinces caused by the Hurricane Laura. Aniline consumption by the manufacturers of methylene diphenyl diisocycanate (MDI) showed sharp recovery with better sales figures reported from sectors such as consumer durables and home appliances.</p><p><strong>Chemical Pricing : <a href="https://www.chemanalyst.com/ChemicalPricing/ChecmPriceYearlyChart?regionFID=1&countryFID=1&categoryFID=15&product=1&ChartType=line&Range=Yearly&Customer=False">https://www.chemanalyst.com/ChemicalPricing/ChecmPriceYearlyChart?regionFID=1&countryFID=1&categoryFID=15&product=1&ChartType=line&Range=Yearly&Customer=False</a></strong></p><p></p><p></p><p>Source : ChemAnalyst</p></div>North America Sulphur Fertilizers Market Forecast & Opportunities, 2025https://globalriskcommunity.com/profiles/blogs/north-america-sulphur-fertilizers-market-forecast-amp2020-03-02T08:16:05.000Z2020-03-02T08:16:05.000ZTechsci Researchhttps://globalriskcommunity.com/members/TechsciResearch<div><p style="text-align:left;"><a href="{{#staticFileLink}}8028315083,original{{/staticFileLink}}" target="_blank"><img src="{{#staticFileLink}}8028315083,original{{/staticFileLink}}" class="align-center" alt="8028315083?profile=original" /></a></p><p style="text-align:left;"><strong>North America sulphur fertilizers market was valued at $ 1.7 billion in 2019 and is forecast to cross $ 2.4 billion by 2025.</strong> Growth in the regional market can be attributed to rising population coupled with limited arable land. Increasing sulphur deficiency and growing demand for food are expected to propel the sulphur fertilizers market of North America through 2025.</p><p style="text-align:left;"><strong>Browse the Complete Report: "<a href="https://www.techsciresearch.com/report/north-america-sulphur-fertilizers-market/4480.html" target="_blank">North America Sulphur Fertilizers Report</a>"</strong></p><p style="text-align:left;">Sulphur fertilizers play crucial role in providing nutrients to crops for formation of chlorophyll that plants use for photosynthesis. Furthermore, it is useful in the activation of enzymes and helps to improve protein and oil percentage in seeds.</p><p style="text-align:left;"><strong>Download the Sample @ <a href="https://www.techsciresearch.com/sample-report.aspx?cid=4480">https://www.techsciresearch.com/sample-report.aspx?cid=4480</a></strong></p><p style="text-align:left;">TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the product offerings, distribution channels and presence of all major manufacturers across the globe.</p><p style="text-align:left;">TechSci Research calculated the market size of North America sulphur fertilizers market using a bottom-up approach, where data for various end-user segments was recorded and forecast for the future years.</p><p style="text-align:left;">TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.</p></div>North America Cannabis Market Share and Industry Report (2019-2025)https://globalriskcommunity.com/profiles/blogs/north-america-cannabis-market-share-and-industry-report-2019-20252019-06-07T12:30:00.000Z2019-06-07T12:30:00.000ZBIS Researchhttps://globalriskcommunity.com/members/BISResearch<div><p>Medical cannabis is increasingly becoming a popular alternative to traditional pain-relieving medications by demonstrating huge potential to provide various pain symptoms raging from being acute to chronic. The analgesic properties of cannabis help to ease pain resulting from nerve damage and inflammation and are also proven to be useful for inflammatory pain in arthritis patients and pain associated with severe illnesses like cancer and AIDS. Other than pain management, notable medical application areas of cannabis include muscle spasm, headaches, anxiety, vomiting, and nausea, among others. Apart from these applications, research studies have demonstrated the efficacy of cannabis for several other medical applications as well, including amyotrophic lateral sclerosis (ALS), asthma, autoimmune disorders, and certain neurodegenerative disorders like Alzheimer's disease, among others.</p><p><strong>Request the Sample @ <a href="https://bisresearch.com/requestsample?id=702&type=download">https://bisresearch.com/requestsample?id=702&type=download</a></strong></p><p>However, out of all these application areas, pain management dominated the market in 2018 and accounted for 39.06% of the total market share of North America cannabis market, by medical application. It further demonstrated the fastest growth rate (CAGR: XX%) owing to the huge adoption of medical cannabis for different pain associated clinical conditions.</p><p>In 2018, the <strong><a href="https://bisresearch.com/industry-report/north-america-cannabis-market.html" target="_blank">North America Cannabis market</a></strong> by distribution channel, is largely dominated by retail sales that accounted for almost XX% of the total market share. Presence of huge number of retail store outlets distributed across the country of the U.S. and Canada attributed to the huge contribution of revenue to the North America cannabis market. In addition, increased preference of customers of buying cannabis products from retail stores also contributed significantly in the growth of the cannabis market (retail sales). However, e-commerce sales of cannabis are expected to witness a higher growth rate as compared to retail sales. Ease of availability of cannabis products through online sales and shifting trend of companies toward the promotion of online platform for e-commerce sales of cannabis are held to be responsible for driving the growth of the North America cannabis market(e-commerce sales).</p><p><strong>About Us:</strong></p><p>BIS Research is a global market intelligence, research and advisory company which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market over the next five (or ten) years.</p><p>With over 150 market intelligence reports published annually, BIS Research focuses on various technology verticals such as 3D printing, advanced materials & chemicals, aerospace and defense, automotive, healthcare, electronics & semiconductors, robotics & UAV and other emerging technologies.</p><p>Each research report incorporates detailed analysis and subsequent quantification of- market dynamics, market drivers and restraints, opportunities, threats, market shares, current and emerging industry trends as well as detailed competitive landscape and intelligence.</p><p><strong>Contact:</strong></p><p><strong>39111 PASEO PADRE PKWY STE 313,</strong><br /><strong>FREMONT CA 94538-1686,</strong> <br /><strong>E-mail : sales@bisresearch.com</strong><br /><strong>Call Us : +1-510-404-8135</strong></p><p></p></div>Putting Profitability at Risk – Banking IT investment is on the Rise, but will we see a Long-Term Downfall of the Short-Sighted?https://globalriskcommunity.com/profiles/blogs/putting-profitability-at-risk-banking-it-investment-is-on-the2013-08-07T12:45:49.000Z2013-08-07T12:45:49.000ZMarkus Gujerhttps://globalriskcommunity.com/members/MarkusGujer<div><p>According to a report published by Technology Business Research last week, IT investment among North American banks is on the rise, with one of the main drivers for this being data management. This echoes findings of research SunGard recently conducted into risk management trends and priorities among more than 750 of our banking customers in 60 countries. Over 50% of respondents confirmed that their IT budgets for risk management has increased or remained stable since 2012. In the US, 65% of banks see an increase in IT budgets for risk management compared to just 3% that expect a decrease.</p><p>All these statistics point to an encouraging wave of IT investment that many would argue is long overdue. The investment is there, but when it comes to risk management, will current bank strategy effectively guide this investment for the long term good? The view that banks are taking a short-term approach to risk management is not necessarily new, but in a world where regulatory tapestry keeps getting richer and IT budgets get bigger, why are we still being short-sighted when it comes to risk?</p><p>While it’s true that regulation is inevitably a major driving force for how banks are approaching risk management post-crisis, this also arguably creates a short-sighted view of what CEOs are classifying as key concerns and priorities in this area. Many would agree that banks worldwide are in a no-win situation as the rope of regulation gets pulled tighter, yet there is often lack of definition around regulatory requirements. This leaves the industry finding itself putting its risk management eggs in the basket of those who are shouting loudest. In the U.S. it is Dodd-Frank beating the stress-testing drum while in Europe the Basel III liquidity risk rules driving the risk management agenda.</p><p>Amid all the current compliance kafuffle, are banks putting profitability at risk by neglecting a longer-term view? Can banks strike a balance when it comes to formulating risk management strategies that address immediate requirements yet lay the foundation for a strategic risk framework that will help drive competitive advantage and profitability from sound risk management?</p><p>To explore these questions, we spoke to more than 750 firms across 60 countries about their risk management priorities and concerns. While the findings show there is more investment being made in the risk management area, it appears that a lot of resources are still being dedicated to addressing short-term requirements.</p><p>Key findings of SunGard’s risk trends research included:</p><p>C-level and management concerns towards risk and regulations appear to be reactive and short-term: Nearly 30% of respondents are concerned with current regulatory and economic uncertainty compared to concerns relating to having the right in-house risk management expertise and cultural challenges in aligning the front line with risk-taking goals, which are among the lowest at approximately 7%.</p><p>Changing priorities suggest reactive risk management planning: Only two of 10 risk priorities maintained the same ranking among global institutions in 2013 compared to 2012 (liquidity risk management and risk appetite framework). Capital planning is ranked by these firms as the second–from-last priority, having been one of the top three last year. The priorities of U.S. firms changed most in the area of capital adequacy assessment**, with economic capital falling from the top priority last year to number eight. The top four 2013 global risk priorities are liquidity risk management, regulatory capital adequacy, credit portfolio optimization and risk appetite.</p><p>Smaller banks lag larger counterparts in risk management progress: 15% of U.S. firms with <$10Bn in assets have no plans to develop a stress-testing process compared to all institutions with $10Bn-$50Bn in assets, which have either completed a stress test already or expect to develop one in the next 12 months. All banking institutions in the U.S. with >$50Bn in assets have completed an enterprise-wide stress test.</p><p>It is clear that turbulence in regulatory change is shaping short-term attitudes to risk management, which could affect future profitability in the financial industry. At a time when risk management budgets are increasing to respond to regulation, firms must begin to adopt a long-term approach to risk and compliance to help drive competitive advantage and future revenue. As the TBR report claims, increased IT investment is expected to change a banks operating model from one that is ‘run the bank’ to ‘change the bank’ led. This supports what needs to happen in a banks approach to risk management. It should not simply be about running the bank today and addressing regulations as they arise, but evolving the bank’s operational risk infrastructure to support a long term, proactive and strategic approach to the practice of risk management and regulatory compliance. Those that continue to view risk management as a tick-box exercise may struggle to successfully compete in the new, regulatory-driven era of financial services.</p><p> </p><p>(Original source - RiskTech forum)</p></div>